Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond

MLA

Cesar A. Perez, et al. “Novel Targeted Therapies for Resistant ALK-Rearranged Non-Small-Cell Lung Cancer: Ceritinib and Beyond.” OncoTargets and Therapy, vol. 8, Apr. 2015, pp. 885–92. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a673391082c99e9b4c23b8619bcee417&authtype=sso&custid=ns315887.

APA

Cesar A. Perez, Ajit Paintal, Goetz H. Kloecker, & Zeyad Kanaan. (2015). Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond. OncoTargets and Therapy, 8, 885–892.

Chicago

Cesar A. Perez, Ajit Paintal, Goetz H. Kloecker, and Zeyad Kanaan. 2015. “Novel Targeted Therapies for Resistant ALK-Rearranged Non-Small-Cell Lung Cancer: Ceritinib and Beyond.” OncoTargets and Therapy 8 (April): 885–92. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a673391082c99e9b4c23b8619bcee417&authtype=sso&custid=ns315887.